Impact of Diabetes on Mortality in Patients With Myocardial Infarction and Left Ventricular Dysfunction | Zendy

Alvaro M. Murcia | Zendy; Charles H. Hennekens | Zendy; Gervasio A. Lamas | Zendy; Manuel F. JiménezNavarro | Zendy; Jean L. Rouleau | Zendy; Greg C. Flaker | Zendy; Steven Goldman | Zendy; Hicham Skali | Zendy; Eugene Braunwald | Zendy; Marc A. Pfeffer | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Impact of Diabetes on Mortality in Patients With Myocardial Infarction and Left Ventricular Dysfunction

Author(s) -

Alvaro M. Murcia,

Charles H. Hennekens,

Gervasio A. Lamas,

Manuel F. JiménezNavarro,

Jean L. Rouleau,

Greg C. Flaker,

Steven Goldman,

Hicham Skali,

Eugene Braunwald,

Marc A. Pfeffer

Publication year - 2004

Publication title -

archives of internal medicine

Language(s) - English

Resource type - Journals

eISSN - 1538-3679

pISSN - 0003-9926

DOI - 10.1001/archinte.164.20.2273

Subject(s) - medicine , killip class , cardiology , myocardial infarction , diabetes mellitus , ejection fraction , captopril , blood pressure , heart failure , placebo , endocrinology , alternative medicine , pathology

Diabetes is a major risk factor for developing coronary heart disease. In patients with diabetes who survived myocardial infarction (MI), less is known about subsequent morbidity and mortality. We evaluated the effects of diabetes in post-MI patients with left ventricular dysfunction on cardiovascular events and death.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research